Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Lenvatinib is a potent anti-cancer drug specifically designed to treat certain types of thyroid cancer, with potential applications in other cancers.
Developed by Eisai Co., this medication functions as a multiple kinase inhibitor, effectively targeting VEGFR1, VEGFR2, and VEGFR3 kinases. By inhibiting these key kinases,